for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Maybe Pfizer's offer won't be the last?

Posted

May.27 - Shares in AstraZeneca fell 2.3 percent after U.S. drugmaker Pfizer said it would not make a formal bid to acquire its smaller British rival. But, as Ciara Sutton reports, many believe Pfizer may try again later this year.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up